Readministration of EGFR Tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients after Initial Failure, What Affects its Efficacy?
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7035-7035
2015 ◽
Vol 138
(4)
◽
pp. 1003-1012
◽
2008 ◽
Vol 58
(2)
◽
pp. AB33